Efficacy and safety of antifungal additives in Optisol-GS corneal storage medium

JAMA Ophthalmology

Volumn 132, Issue 7, 2014, Pages 832-837

  Layer, Noelle ^a   Cevallos, Vicky ^b   Maxwell, Andrew J ^c   Hoover, Caroline ^c   Keenan, Jeremy D ^a,b   Jeng, Bennie H ^a,b,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Francis I Proctor Foundation   (United States)

^c SightLife   (United States)

^d SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; VORICONAZOLE;

ARTICLE; BACTERIUM CONTAMINATION; CANDIDA ALBICANS; CANDIDA GLABRATA; CELL DENSITY; CONTROLLED STUDY; CORNEA; CORNEAL STORAGE MEDIA; DONOR; DRUG EFFICACY; DRUG SAFETY; ENDOTHELIUM CELL; EPITHELIUM CELL; FREEZING; HUMAN; IN VITRO STUDY; LABORATORY; MINIMUM INHIBITORY CONCENTRATION; ORGAN PRESERVATION; PRIORITY JOURNAL; ROOM TEMPERATURE; SEPARATION TECHNIQUE; STAINING; WARMING;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDIASIS; CELL COUNT; CHONDROITIN SULFATES; COLONY COUNT, MICROBIAL; COMPLEX MIXTURES; CORNEA; CULTURE MEDIA, SERUM-FREE; DEXTRANS; DRUG COMBINATIONS; DRUG CONTAMINATION; ENDOTHELIUM, CORNEAL; GENTAMICINS; HUMANS; MICROBIAL SENSITIVITY TESTS; ORGAN PRESERVATION; ORGAN PRESERVATION SOLUTIONS; PYRIMIDINES; TISSUE DONORS; TREATMENT OUTCOME; TRIAZOLES;

EID: 84904209218     PISSN: 21686165     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaophthalmol.2014.397     Document Type: Article

References (27)

1. Hassan SS, Wilhelmus KR; Medical Review Subcommittee of the Eye Bank Association of America. Eye-banking risk factors for fungal endophthalmitis compared with bacterial endophthalmitis after corneal transplantation. Am J Ophthalmol. 2005;139(4):685-690.
2. Kloess PM, Stulting RD, Waring GO III, Wilson LA. Bacterial and fungal endophthalmitis after penetrating keratoplasty. Am J Ophthalmol. 1993; 115(3):309-316. (Pubitemid 23081070)
3. Taban M, Behrens A, Newcomb RL, Nobe MY, McDonnell PJ. Incidence of acute endophthalmitis following penetrating keratoplasty: a systematic review. Arch Ophthalmol. 2005;123(5):605-609. (Pubitemid 40695507)
4. Aiello LP, Javit JC, Canner JK. National risks of endophthalmitis and retinal detachment following penetrating keratoplasty. Arch Ophthalmol. 1993;111(4):509-513. (Pubitemid 23116898)
5. Aldave AJ, DeMatteo J, Glasser DB, et al. Report of the Eye Bank Association of America medical advisory board subcommittee on fungal infection after corneal transplantation. Cornea. 2013;32(2):149-154.
6. Merchant A, Zacks CM, Wilhelmus K, Durand M, Dohlman CH. Candidal endophthalmitis after keratoplasty. Cornea. 2001;20(2):226-229. (Pubitemid 32174101)
7. Caldwell MC, Perfect JR, Carlson AN, Proia AD. Candida glabrata endophthalmitis following penetrating keratoplasty. J Cataract Refract Surg. 2009;35(3):598-602.
8. Keyhani K, Seedor JA, Shah MK, Terraciano AJ, Ritterband DC. The incidence of fungal keratitis and endophthalmitis following penetrating keratoplasty. Cornea. 2005;24(3):288-291. (Pubitemid 40418337)
9. Wilhelmus KR, Hassan SS. The prognostic role of donor corneoscleral rim cultures in corneal transplantation. Ophthalmology. 2007;114(3):440-445. (Pubitemid 46282961)
10. Chu YI, Penland RL, Wilhelmus KR. Colorimetric indicators ofmicrobial contamination in corneal preservationmedium. Cornea. 2000;19(4):517-520. (Pubitemid 30460892)
11. Ritterband DC, Shah MK, Meskin SW, et al. Efficacy and safety of voriconazole as an additive in Optisol GS: a preservation medium for corneal donor tissue. Cornea. 2007;26(3):343-347. (Pubitemid 46568836)
12. Sabo JA, Abdel-Rahman SM. Voriconazole: a new triazole antifungal. Ann Pharmacother. 2000;34(9):1032-1043. (Pubitemid 30660782)
13. Pfaller MA, Messer SA, Boyken L, Tendolkar S, Hollis RJ, Diekema DJ. Selection of a surrogate agent (fluconazole or voriconazole) for initial susceptibility testing of posaconazole against Candida spp: results from a global antifungal surveillance program. J Clin Microbiol. 2008;46(2):551-559. (Pubitemid 351231301)
14. Marangon FB, Miller D, Giaconi JA, Alfonso EC. In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens. Am J Ophthalmol. 2004;137(5):820-825. (Pubitemid 38582033)
15. Clinical and Laboratory Standards Institute (CLSI). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Third Informational Supplement. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.CLSI document M27-S3.
16. Thomas PA. Current perspectives on ophthalmicmycoses. Clin Microbiol Rev. 2003;16 (4):730-797.
17. Clinical and Laboratory Standards Institute (CLSI). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard-Third Edition. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.CLSI document M27-A3.
18. Park S, Fong AG, Cho H, et al. Protocol for vital dye staining of corneal endothelial cells. Cornea. 2012;31(12):1476-1479.
19. Maas-Reijs J, Pels E, Tullo AB. Eye banking in Europe 1991-1995. Acta Ophthalmol Scand. 1997;75(5):541-543. (Pubitemid 28022345)
20. Pels E, Beele H, Claerhout I. Eye bank issues, II: preservation techniques: warm versus cold storage. Int Ophthalmol. 2008;28(3):155-163.
21. Fontana L, Errani PG, Zerbinati A, Musacchi Y, Di Pede B, Tassinari G. Frequency of positive donor rim cultures after penetrating keratoplasty using hypothermic and organ-cultured donor corneas. Cornea. 2007;26(5):552-556. (Pubitemid 47164712)
22. European Eye Bank Association. Adverse outcomes. In: Directory. 11th ed. Brussels, Belgium: European Eye Bank Association; 2003.
23. Klepser ME, Ernst EJ, Lewis RE, Ernst ME, Pfaller MA. Influence of test conditions on antifungal time-kill curve results: proposal for standardizedmethods. Antimicrob Agents Chemother. 1998;42(5):1207-1212. (Pubitemid 28227921)
24. Smith TM, Popplewell J, Nakamura T, Trousdale MD. Efficacy and safety of gentamicin and streptomycin in Optisol-GS, a preservation medium for donor corneas. Cornea. 1995;14(1):49-55.
25. Hariprasad SM, Mieler WF, Lin TK, Sponsel WE, Graybill JR. Voriconazole in the treatment of fungal eye infections: a review of current literature. Br J Ophthalmol. 2008;92(7):871-878. (Pubitemid 351969658)
26. Kernt M, Neubauer AS, De Kaspar HM, Kampik A. Intravitreal voriconazole: in vitro safety-profile for fungal endophthalmitis. Retina. 2009;29(3):362-370.
27. Kim SY, Yang J, Lee YC. Safety ofmoxifloxacin and voriconazole in corneal storage media on porcine corneal endothelial cells. J Ocul Pharmacol Ther. 2010;26(4):315-318.